In an era dominated by rapid technological advancements and ever-evolving work dynamics, the concept of the workplace has undergone a profound transformation. The days when an actual office location ...
-- Presented at the AAD VMX 2020, results from ECZTRA 1, 2 and 3 trials confirm tralokinumab met its primary and secondary endpoints and are the first Phase 3 results in atopic dermatitis for an ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More In February, Nvidia was hit with a cyberattack by Lapsus$, an ...
Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Regulatory trials of chimeric antigen receptor T-cell therapies for autoimmune diseases could be ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- A ...